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   Proteins are fundamental components of cells which mediate many essential biological processes. 
Proteomics is a rapidly growing field for the study of proteome, the protein complement expressed by the 
genome of an organism or cell type. The large-scale analysis of proteins leads to a more comprehensive view 
of molecular and cellular pathways that improves the overall understanding of the complex processes 
supporting the living systems. The analysis of proteome is significantly challenging due to high dynamic 
range and difficulties in assessment of low abundance proteins and the absence of efficient purification and 
identification techniques. A variety of methods have been utilized for protein studies including gel-based 
techniques, protein microarrays, mass spectrometry-based approaches such as MALDI and SELDI, high and 
ultra-performance liquid chromatography and fourier transform ion cyclotron resonance mass spectrometry. 
NMR spectroscopy and X-Ray crystallography methods are also used for structural study of proteins. This 
review aims to give a brief overview of some of the above techniques and their most recent advances. We 
also introduce Proteominer, a recent protein enrichment technology for the exploration of the entire 
proteome content. 
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INTRODUCTION 
     The analysis of proteins has undergone  a 
major revolution over the past 20 years from 
amino acid analysis and Edman sequencing to 
today mass spectrometry platforms[1]. One of the 
first techniques used in proteomics is 2D-gel 
electrophoresis. The great advantage of modern 
2D gel-based proteomic experiments is that it is 
simple and robust technology and can be quickly 
implemented into most laboratories[2]. Unlike 
gel-based approaches, MS-based relative 
quantitation techniques usually rely on an initial 
digestion of the protein, and the subsequent 
protein quantification is actually based on the 
quantitation of proteotypic peptides that act as 
surrogates for the proteins of interest[3]. Mass 
spectrometry is an extraordinary information rich 
technology that is capable of detecting tens of 
thousands of peptides generated in a single 
separation[4]. Mass spectrometry-based 
approaches are uniquely well suited in terms of 
throughput and sensitivity to handle proteome-
wide investigations[5]. There are two main types 
of mass spectrometric analysis approaches, “Top-
Down” and “Bottom-Up” or shotgun. In “Bottom-
Up” proteomics, peptides generated from 
enzymatic proteolysis of proteins are analyzed in 
a mass spectrometer[1]. In top-down proteomics, 
100% sequence coverage is obtained and PTM 
combinations are preserved leading to precise 
identification of proteins. In shotgun proteomics, 
protein mixtures are proteolytically digested 
before tandem mass spectrometry (MS/MS) 
analysis. To reduce sample complexity and 
increase the chances of identifying low abundant 
proteins, fractionation techniques are performed 
such as multidimensional protein identification 
technology approach (MudPIT), where peptides 
are separated by strong cation exchange (SCX) 
and reversed phase chromatography prior to their 
identification by mass spectrometry (MS). Protein 
and peptide fractionations using electrophoresis is 
also common because of its high capability and 
resolving power[6]. Accurate quantification of 
 




proteins at proteome level has become one of the 
key issues in protein science. Therefore, 
quantitative proteomics, emerged as a new 
research area in the last decade. Stable isotope 
labeling and label free techniques are used for this 
purpose. Label free methods include ion 
intensities of peptides and spectral counting but 
its usage is limited because of high variability in 
sample preparation and instrumental analysis. 
This challenge is addressed by stable isotope 
labelling methods. Since such labeling does not 
affect the chemical properties of proteins, the 
heavily and lightly labeled samples could be co-
eluted from the LC-column, followed by the 
simultaneous analysis in the mass 
spectrometer[7]. Some of the major isotope 
labeling techniques are SILAC, iTRAQ and 
ICAT. Structural proteomics is the systematic 
investigation of the three-dimensional structures 
of the protein products of genes. Because of the 
challenge in structure determination of large 
numbers of proteins, the field of structural 
proteomics developed [8]. NMR spectroscopy and 
X-Ray Crystallography are widely used in this 
area. The following paper aims to discuss briefly 
major technologies in the field of proteomics. 
MS-based methods, two-dimensional gel 
electrophoresis and some novel gel- and non-gel-
based methods, isotope-labeling and label-free 
techniques are studied. After talking about 
microarray and proteominer technologies, 




    MALDI (Matrix-Assisted Laser 
Desorption/Ionization), in combination with TOF-
MS (time of flight- mass spectrometry), has 
emerged as a valuable technique for identification 
of proteins. MALDI can be applied for 
compounds in the m/z range of 500 to over 
100,000[9]. MALDI-TOF instruments are 
relatively simple to use, have high mass accuracy 
and are reasonably tolerant of contaminants and 
solvents[10]. The first reports of MALDI-TOF-
MS biochemical analysis were published in the 
late 1980s from Karas and Hillenkamp lab[11]. 
MALDI has significantly revolutionized 
approaches to the study of biomolecules. MALDI 
is initiated by mixing the sample solution with 
matrix material and depositing the mixture on a 
specially designed MALDI sample target. After 
evaporation of the solvent, the sample–matrix 
crystals are irradiated using laser beam of high 
irradiance and short pulse widths to 
simultaneously desorb and ionize the sample and 
matrix molecules into the gas phase (see Figure1). 
An essential key to success of MALDI is a matrix 
that is able to absorb a large amount of energy at 
the wavelength of the laser radiation, and then 
relays it to the sample molecules in a controlled 
manner to permit desorption of even massive 
molecules as intact gas-phase ions. The MALDI-
generated ions are mainly singly protonated 
molecules. Oligomeric ions and doubly and triply 
charged protonated ions are also formed. Because 
the irradiating laser beam is pulsed, MALDI is 
optimally combined with a TOF mass analyzer. 
The unlimited mass range of TOF and its ability 
to acquire the entire spectrum from a single laser 
pulse event are other factors in favor of the 
MALDI/TOF-MS combination. A TOF analyzer 
measures the time taken for the gas-phase ions to 
travel from the ionization source to the detector, 
which is then related to the m/z ratio[12-14]. TOF 
analyzer is based on the fact that ions with the 
same energy but different masses travel with 
different velocities. Basically, ions formed by a 
short ionization event are accelerated by an 
electrostatic field to a common energy and travel 
over a drift path to the detector. The lighter ones 
arrive before the heavier ones and a mass 
spectrum is recorded. Measuring the flight time 
for each ion allows the determination of its mass. 
MALDI –TOF has become a well-known 
acronym for many researchers. A variety of laser 
systems have found applications in MALDI 
analysis, and the most common ones use UV 
lasers such as the N2 laser (337 nm).  
 
 
Figure 1.  MALDI-TOF mass spectrometry 
 




IR lasers have also been used to produce the 
MALDI effect. UV and IR lasers yield similar 
spectra for proteins, although better resolution has 




     SELDI-TOF-MS is an adaptation of MALDI-
TOF-MS using surface-modified target plates[16]. 
This technology was introduced in 1993 by 
Hutchens and Yip for the first time. SELDI is an 
advanced approach to protein profiling and new 
biomarker discovery. SELDI‑TOF has developed 
in clinical research world, especially because of 
its high‑throughput capability. Main features are 
its sensitivity of detection, accuracy of 
quantification and its capability of generating 
reproducible patterns in different laboratories[17]. 
Since, biological samples (like blood and urine) 
are complex mixtures, SELDI is a powerful tool 
that overcomes purification and separation of 
proteins prior to mass spectrometry analysis 
(figure 2). In this technique, microliters of the 
sample are incubated onto the chip surface and 
the chips are then washed using washing buffers. 
The sample is typically analyzed with time-of-
flight mass spectrometry[18].  
The differential expression data obtained from 
this technology has been used for identification of 
biomarker candidates for various cancer types, 
such as prostate[19], pancreas[20], lung[21], 
breast[22], melanoma[23], and liver cancers[24]. 
For most cancers, survival rates depend on the 
early detection of the disease. Novel mass 
spectrometry (MS)-based technologies in 
particular, SELDI-TOF-MS,  have brought the 
hope of discovering new cancer-specific 
biomarkers in  biological samples and have shown 
promising results in the recent literature[25]. 
The SELDI-TOF-MS technology is not only able 
to find single protein biomarkers but is also able 
to identify biomarker expression patterns. 
Proteomic pattern analysis is a novel approach for 
the diagnosis of diseases[26]. 
In summary, there is considerable hope that this 
new proteomic technology will be used 
significantly to screening-test development in 
routine clinical practice[25]. 
An advantage of SELDI-TOF-MS is its relatively 
high tolerance for salts and other impurities. The 
sample requirement is low and sample volume 




Figure 2. SELDI-TOF mass spectrometry 
 
FT-ICR mass spectrometry 
    Fourier transform ion cyclotron resonance mass 
spectrometry, also known as Fourier transform 
mass spectrometry, is a type of mass analyzer (or 
mass spectrometer) for determining the mass-to-
charge ratios (m/z) of ions based on the cyclotron 
frequency of the ions in a fixed magnetic field. 
The FT-ICR mass analyzer, introduced in 1974, 
has the highest mass resolving power and best 
mass measurement accuracy among current mass 
analyzers. The orbitrap, another Fourier transform 
mass analyzer, invented in 1999, has been widely 
distributed since its commercial introduction in 
2004. In an FT-ICR instrument, ions are first 
generated at the source (ESI, APCI, APPI, or 
MALDI), and then injected into an ion trap mass 
analyzer cell in the center of a magnetic field (The 
highest field of FT-ICR instrument is currently 15 
T, and 21 T systems are under construction). 
Fourier transform ion cyclotron resonance mass 
 




spectrometry is based on image current detection 
of coherently excited ion cyclotron motion. It is 
now one of the most sensitive methods of ion 
detection in existence and has almost unlimited 
resolution >10
7
, with most experiments taking 




 range. FT-ICR–MS is also 
a powerful tool for conducting ion–molecule 
reactions and for structure elucidation studies. 
Because of these useful features, FT–ICR–MS in 
conjunction with ESI has emerged as the most 
powerful form of mass spectrometry for the 
analysis of biomolecules[27-29]. 
 
GEL-BASED METHODS 
Two-dimensional gel electrophoresis 
    Two-dimensional gel electrophoresis (2DE) has 
become the most widely used separation tool in 
proteomic analysis. 2DE is especially useful in 
expression proteomics, where comparative 
analysis of the expression of proteins exposed to 
environmental factors and those physically 
undisturbed is the purpose of research[30].This 
method was first described by O‟farrell in 1975 
and has developed till then. 2D electrophoresis 
consists of two tandem steps (dimensions). The 
first dimension is called isoelectric focusing 
(IEF). In this step, proteins are separated based on 
their isoelectric points in an electric field in a pH 
gradient. The gradient is generated using both 
carrier ampholytes or immobilized pH gradient 
(IPG) strips. IPG is obtained by copolymerization 
of acrylamide with immobilin. The pH gradients 
with IPG are more stable and reproducible. 
Today, commercially IPG strips are available with 
different length and pH ranges. Second dimension 
in 2D electrophoresis is SDS-PAGE (sodium 
dodecylsulfate polyacrylamide gel 
electrophoresis) which separates the proteins 
according to their molecular weights. After 
separation of the proteins on the gel, they are 
visualized by staining with different dyes usually 
coomassie blue, silver nitrate, and fluorescent 
dyes. The stained spots are then excised and 
digested for further identification. 
 
2D-DIGE 
     2D-DIGE (2-dimensional difference gel 
electrophoresis) technique was first described by 
Jon Minden‟s laboratory. It relies on pre-
electrophoretic labeling of samples with one of 
fluorescent CyDyes (Cy2, Cy3 and Cy5) allowing 
multiplexing of samples into the same gel (figure 
3). 2D-DIGE is effectively used for the study of 
various systems and enables detection of subtle 
changes in protein expression than conventional 
2D-PAGE[31]. 2D-DIGE has some advantages. It 
is labor and time saving and produces accurate 
and reliable results. Furthermore, loss of proteins 
is reduced because no post-electrophoretic 
processing is needed. 
 
 
Figure 3. 2D-DIGE 
 
Tube Gel Electrophoresis 
     Tube gel electrophoresis utilizes a tube gel 
column to separate proteins which are then 
collected as they elute from the end of the gel 
column. The use of tube gel electrophoresis was 
further expanded with the invention of gel-eluted 
liquid fraction entrapment electrophoresis 
(GELFrEE). It uses a sample collection chamber 
in which fractions are manually collected which 
ensures that higher molecular weight proteins are 
not continually diluted and dispersed across many 
fractions. It has a short gel column which reduces 
separation time 75%[5], (Figure 4). 
 





Figure 4. tube gel electrophoresis (Adam D. Catherman OSS et al., 2014) 
 
Off-gel Electrophoresis 
    Gel free techniques are very important in 
separating proteins. A gel-free approach in protein 
separations is immobilized pH gradient (IPG) IEF 
where peptides can be recovered from the liquid 
phase (offgel electrophoresis) which leads to 
efficient protein fractionation and identification 
[32]. Jonson and Rilbedeveloped a gel-free 
multicompartmentelectrolyser electrophoretic 
device with IPG technology which provided better 
pI resolutions. A further technology is developed by 
Girault et al. which includes adapting the off-gel 
IEF to a multiwell format. The multiwell device is 
composed of different compartments of 100 or 300 
μL open at the top and bottom extremities and 
placed on an IPG gel conditioned with a thin layer 
of solution containing buffers. There is no fluidic 
connection between the wells, and the charged 
proteins migrate through the gel across the wells 
under the applied electric field until they reach net 
charge of zero (pI), in which the proteins will be in 
the solution and can be recovered in the liquid 
phase[32]. 
 
STABLE ISOTOPE LABELLING METHODS 
     In these methods, proteome samples are labeled 
and then mixed and subjected to LC/MS analysis. 
The quantification of proteins is achieved by 
comparing of MS peak intensities from labeled and 
non-labeled samples. A variety of isotopic labeling 
techniques can be used for relative quantification, 
including SILAC, iTRAQ and ICAT.  
 
Stable Isotope Labeling by Amino Acids in Cell 
Culture (SILAC), is a metabolic labeling strategy 
that encodes whole cellular proteomes. Cells are 
grown in a culture medium where the natural 
form of an amino acid is replaced with a stable 
isotope form such as arginine with six 
13
C atoms. 
Incorporation of the “heavy” amino acid occurs 
through cell growth and protein synthesis. The 
“light” and “heavy” proteomes belonging to two 
samples are then distinguished via mass 
spectrometry[33]. 
“SILAC” has some potential limitations too. For 
example, although metabolic labeling is an 
effective way to uniformly incorporate isotopic 
tags into proteins, in practice, it is not always 
feasible as seen with clinical samples and some 
model organisms. Also the ion intensity for each 
peptide is distributed between several isotopic 
peaks which lowers the total number of peptide 
identifications from a given sample[34]. 
iTRAQ (isobaric tags for relative and absolute 
quantitation) reagents are a set of multiplexed 
amine specific stable isotope reagents which 
consists of a reporter group based on N,N-
dimethylpiperazine, a mass balance carbonyl 
group, and a peptide-group. When iTRAQ reagent 
reacts with a peptide, it forms an amine linkage to 
any peptide amine like lysine amino group.A new 
method known as “NeuCode SILAC” is recently 
introduced which is a combination of SILAC 
metabolic labeling with multiple isobaric tags. 
This  method  has  remarkable  efficiency  and  
 




resolution to distinguish between isotopes of 
similar mass, based up on differences in nuclear 
binding energy[34]. 
The ICAT peptide labeling technique 
differentiates between two populations of proteins 
using reactive probes that differ in isotope 
composition. ICAT reagents consist of a protein-
reactive group, a linker region and a biotin tag. 
The two different  isotope tags are generated by 
using linkers composed of either eight deuterium 
atoms (d8, heavy reagent) or eight hydrogen 
atoms (d0, light reagent). A reduced protein 
sample from one specimen is derivatized with the 
isotopically heavy version of the ICAT reagent, 
while the other reduced protein sample is 
derivatized with the isotopically light version of 
the ICAT reagent. The two samples are combined 
and digested with a protease, such as trypsin or 
Lys-C, to produce peptide fragments. The 
combined sample is then subjected to avidin 
affinity chromatography and only cysteine-
containing peptides are thus retrieved. MS is used 
to reveal the ratio of the isotopic molecular 
weight peaks that differ by 8 Da, and this gives a 
measure of the relative amounts of each protein 
from the original samples[35]. 
 
LABEL FREE METHODS 
    Label-free approaches are divided into two 
main categories: spectral counting and mass 
spectrometric signal intensities. Spectral counting 
implies a counting and comparison of the number 
of fragment ion spectra (MS/MS) for peptides of a 
given protein. Due to the role of protein 
concentration on the number of tandem mass 
spectra of a peptide, a relative quantification of 
proteins between different samples is possible. 
Signal intensity method, relies on the intensity of 
the mono-isotopic mass peak and measurement of 
chromatographic peak areas[36].   
 
PROTEIN MICROARRAY 
Novel proteomics technology is valuable for 
studying of whole proteome and network analysis. 
Protein microarrays, an emerging class of 
proteomic technologies, are fast becoming critical 
tools in biochemistry and molecular biology[37]. 
Protein microarray is a high throughput tool for 
studying the biochemical activities of proteins, 
tracking their interactions, and determining their 
function on a large scale[38]. Protein microarray 
chips that contain immobilized proteome, are 
being developed to simultaneously analyze 
protein function and protein-protein, protein-DNA 
or protein-ligand interactions in a  
high‑throughput in vitro manner in a single 
experiment[39]. The  chip usually  consists of a 
support surface such as a glass slide, 
nitrocellulose membrane, bead, or microtiter plate 
to which an array of capture proteins is 
bound[18]. This method can be divided to two 
types, forward-phase and reverse-phase arrays[40, 
41]. In forward-phase protein arrays (FPPA), an 
antibody as a capture molecule for a target protein 
is immobilized onto a glass slide robotically and 
cell lysate that contains target proteins is 
incubated onto the slide, finally bounded proteins 
are detected using secondary labeled antibody[40, 
42]. In this type, many target proteins in a sample 
can be identified simultaneously. In reverse-phase 
protein arrays (RPPA), protein mixture is 
immobilized onto glass slide and probed with a 
specific antibody against a protein of interest. 
RPPA assays are commonly used in tissue 
microarray and cell and tissue lysate microarray, 
furthermore proteins of interest in a complex 
sample can be detected[43]. New protein 
microarray platforms such as self-assembling 
arrays are emerging, which promise a much easier 
and wider use of the technology to probe protein 




     Proteominer protein enrichment technology is 
a novel and simple sample preparation tool used 
to compress the dynamic range of protein 
concentrations in complex biological samples. For 
example, albumin and IgG in serum or plasma 
make the detection of medium and low-
abundance proteins extremely challenging. 
Proteominer technology provides a method for 
overcoming this challenge allowing the 
exploration of the entire proteome. Proteominer 
technology is based on the interaction of complex 
protein samples with a large, highly diverse 
library of hexapeptides bound to chromatographic 
supports. In theory, each unique hexapeptide 
 




binds to a unique protein sequence. Because the 
bead capacity limits binding capacity, high-
abundance proteins quickly saturate their ligands 
and excess protein is washed out during 
procedure. In contrast, low-abundance proteins 
are concentrated on their specific ligands, thereby 
decreasing the dynamic range of proteins in the 
sample. When analyzed in downstream 
applications, the number of proteins detected is 
dramatically increased[45], (Figure 5). 
 
 




    X-Ray crystallography is one of the two major 
methods for the elucidation of protein structures 
besides NMR spectroscopy. In crystallography, an 
X-ray beam is diffracted by a protein crystal, 
which is a regular lattice of protein molecules 
arranged in a repeating pattern and held together 
by non-covalent forces. Single protein molecules 
cannot scatter sufficient X-rays to be detected, but 
X-rays scattered from a protein lattice combine in 
intensity and can be recorded. Processing of these 
intensities yields a model of the density of 
electrons in the protein crystal. Obtaining well 
diffracting protein crystals often constitutes a 
major bottleneck, since many proteins are difficult 
to crystallize or sometimes do not crystallize at 
all. If crystallization is successful, the use of X-
ray crystallography is advantageous, since it 
offers structural information at atomic resolution 
without a size limit. The X-ray electron density 
map shows a finely detailed, albeit static, 
„„snapshot‟‟ of the protein, typically in its lowest-
energy conformation[46]. 
NMR Spectroscopy 
     NMR spectroscopy plays a major role in 
determination of proteins 3D structures. It is 
utilized to determine structures of smaller proteins 
that fail to form crystals suitable for structure 
determination by x-ray crystallography, to screen 
structural candidates for folding and aggregation 
state, and to screen proteins for binding of metal 
ions, cofactors, or their small molecules. Protein 
NMR spectroscopy requires 1 to 5 mg of purified 
protein, and the protein must be labeled with 
stable isotopes (like nitrogen-15 or carbon-13). 
1D H1 NMR and 2D 15N-1H HSQC spectrums 
usually provide reliable results. Some other 
platforms that can be used include 3D 15N-1H 
NOESY-HSQC, 2D-1H-13C HSQC, 3D-HNCO, 
3D-HNCA, 3D-CCONH, 3D-HCCH-TOCSY and 
so on[8]. NMR spectroscopy has also been used 
for “in-cell” studies of proteins because it non-
invasively gathers data from the cells. It is an 
ideal tool for gaining information about protein 
dynamics at the atomic level[47].This technique 
has been successfully applied in Escherichia coli, 
Xenopuslaevisoocytes and HeLa host cells. 2D-
1H-15N (or 1H-13C) HSQC platform is usually 
used. However, the technique requires that the 
protein of interest is expressed to intracellular 
concentrations sufficient for NMR detection that 
are greater than concentration of most cellular 
proteins[48]. In-cell NMR has several obstacles; 
 




Fewproteins provide high quality NMR spectra 
inside cells.  
Second, in cell NMR is limited by the life span of 
the cells in the NMR tube and even if cells do not 
lyse, they may leak the target protein into the 
media[47].The majority of protein NMR studies 
are carried out in the liquid state. Although 
solution NMR methods have been used to 
characterize unfolded states of proteins, solid-
state NMR techniques provide both qualitative 
and quantitative structural information about 
protein folding, including detailed nature of 
conformational distributions in partially folded 
and unfolded states at equilibrium and the time 
dependence of structural distributions after 
sudden changes in solvent conditions[49]. 
 
CONCLUSION 
     Large scale study of proteins, as a growing 
field in biological sciences, has gained much 
attraction in recent years. One of the most 
important factors in success of the field is the 
evolution of novel techniques for the separation 
and identification of proteins. There are gel-
based, such as 2D-PAGE and 2D-DIGE, and non-
gel-based methods. Mass based methods such as 
MALDI are the most utilized techniques in 
identification of proteins. Stable isotope labeling, 
such as SILAC and iTRAQ, and label free 
methods are used for the accurate quantification 
of proteins at proteome level. In the field of 
structural proteomics, NMR spectrometry and X-
Ray crystallography methods are used. 
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